Company Filing History:
1 out of 1,871 
1 out of 3 
1 out of 824 Years Active: 2020
Title: Innovations by Taylor John Eddens: Pioneering Antigen Identification for Pneumonia
Introduction
Taylor John Eddens is an accomplished inventor based in Pittsburgh, PA, known for his significant contributions to medical research, particularly in the field of pneumonia diagnosis and treatment. With one patent to his name, Eddens has focused on the identification of pneumocystis antigens, which has crucial implications for immunocompromised patients suffering from this life-threatening infection.
Latest Patents
Eddens holds a patent titled "Identification of pneumocystis antigens and uses thereof." This innovation addresses the challenges faced in detecting the organism responsible for pneumonia, especially given that it cannot be cultured and lacks a sequenced genome. The patent outlines a method of surface proteomics, detailing how to reliably detect conserved surface proteins. In this patent, eight distinct surface proteins are identified, alongside methods for eliciting immune responses, generating therapeutic antibodies, and developing diagnostic methods based on these identified peptides.
Career Highlights
Eddens has had a noteworthy career, contributing to significant advancements in medical research related to infectious diseases. His association with prestigious institutions like the University of Pittsburgh and the University of New Orleans has allowed him to collaborate with leading experts in the field and further his research pursuits.
Collaborations
Throughout his career, Taylor John Eddens has collaborated with notable colleagues, including Jay Kennedy Kolls and Mingquan Michael Zheng. These collaborations have played an essential role in the development of his patent and have contributed to the overall understanding and treatment of pneumocystis pneumonia.
Conclusion
In summary, Taylor John Eddens represents a vital link between innovation and medical advancement. His patent on identifying pneumocystis antigens is a testament to his dedication to improving diagnostic methods and therapeutic approaches for pneumonia in vulnerable populations. Through his work, Eddens continues to inspire future research and innovation in the field of healthcare.